The Patent Finder

Terms ending in 2036

Glytec, LLC

Every in-force patent on Glytec, LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,886,556Diabetes Management Therapy Advisor
In force
 · High confidence
Glytec, LLCIn forceHigh confidence
US 10,380,328Diabetes Management Therapy Advisor
In force
 · High confidence
Glytec, LLCIn forceHigh confidence
US 11,574,742Diabetes Management Therapy Advisor
In force
 · Low confidence
Glytec, LLCIn forceLow confidence
US 12,040,096Diabetes Management Therapy Advisor
In force
 · High confidence
Glytec, LLCIn forceHigh confidence
US 12,725,715Diabetes Management Therapy Advisor
In force
 · Medium confidence
Glytec, LLCIn forceMedium confidence
US 11,200,988Diabetes Management Therapy Advisor
In force
 · Medium confidence
Glytec, LLCIn forceMedium confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited